Singapore National Eye Centre

This study tested two treatments for polypoidal choroidal vasculopathy (PCV), an eye disease that can lead to blindness. Sixty patients received either eye injections of aflibercept alone or aflibercept combined with a special light therapy (reduced-fluence PDT). The goal was to …

This study followed 72 people with polypoidal choroidal vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed, and if early treatment succes…